Modernization of Pharmaceutical Regulatory Process ( WEBMODPRP )
Description:
This webinar discusses the FDA's initiative to improve quality of pharmaceutical products including why the pharmaceutical industry and FDA needed to change to have a more modern regulatory process and to deal with more complex products. It specifies the desired state for manufacturing in the 21st Century, "a maximally efficient, agile, flexible pharmaceutical manufacturing sector that reliably produces high-quality drug products without extensive regulatory oversight," and emphasizes what the FDA has done and what it still needs to do to accomplish this desired state. Benefits and challenges of implementing changes also discussed
Objectives:
At the conclusion of this session, participants will be able to:
Learning Catalog